Search This Blog

Saturday, January 18, 2020

Healthcare sector created 399K jobs in 2019

Healthcare created 399,000 new jobs in 2019, up from 350,000 jobs in 2018.


KEY TAKEAWAYS

The 2019 figures include 269,000 jobs in ambulatory services and 107,000 hospital jobs.
More than 16.5 million people work in the healthcare sector at the end of 2019, which accounts for 11% of all jobs in the overall economy.
Nearly one-in-five jobs created in 2019 was in healthcare, which greatly outpaced nearly every other major sector of the economy for the year, federal data released last week show.
For 2019, healthcare created 399,000 jobs—nearly 33,000 new jobs each month—up from 350,000 jobs in 2018. The 2019 figures include 269,000 new jobs in ambulatory services, up from 219,000 jobs in 2018, and 102,000 new hospital jobs, down from 107,000 new jobs in 2018.
More than 16.5 million people work in the healthcare sector at the end of 2019, which accounts for 11% of all jobs in the overall economy.
The new data is in line with BLS projections that healthcare sector employment will grow 18% from 2016 to 2026, “much faster than the average for all occupations, adding about 2.4 million new jobs.”
On the downside, hospital spending will grow about 5.5% each year, from $1.3 trillion in 2018 to $1.8 trillion in 2026, driven largely by those same demographics.
In the overall economy, total nonfarm employment increased by 145,000 in December, lower than expectations, and 2.1 million in 2019, down from 2.7 million in 2018. The unemployment rate ended the year at 3.5%, compared with 3.9% at the end of 2018.
A further breakdown of employment in healthcare shows that the sector ended 2019 with 28,000 new jobs in December, including 23,000 jobs in ambulatory services and 9,000 jobs in hospitals.
At the end of 2019, more than 16.5 million people worked in the healthcare sector, which accounts for nearly 11% of all jobs in the overall economy, including 7.8 million in ambulatory services, and 5.3 million in hospitals.

FTC commissioner pledges hard line on hospital mergers

Horizontal hospital mergers will not escape strict scrutiny from regulators in 2020, a Republican-appointed Federal Trade Commissioner said Thursday, adding the group could review mergers after the fact to determine whether they achieved the cost and quality metrics companies claimed they would.
Christine Wilson said at an event sponsored by the Council for Affordable Health Coverage, a coalition that includes private payers and pro-business groups, that her agency will keep pressing on key healthcare competition stances in 2020, including repeal of state certificate of need laws. FTC will also push for more flexibility in scope of practice laws, particularly for mid-level practitioners, and for keeping biosimilars on the market.
Wilson even suggested support for allowing government programs like Medicare to negotiate drug pricing, a contrast to the traditional GOP stance. The government being a price taker in those situations “seems like a problem,” she said.
But she said many factors that work against competition in the marketplace aren’t under FTC control and need to be fixed by the industry. The key problem is that patients don’t have enough reason or ability to shop around for the best value.
“Information asymmetry and weak or adverse incentives are endemic up and down the healthcare supply chain, unfortunately,” she said.
John Frenzel, director of The Learning Health System at MD Anderson Cancer Center, said burdensome and costly technology and reporting regulations are additional factors in reduced competition in the provider marketplace.
​Hospitals and health systems are employing more doctors as clinicians find it increasingly difficult to manage a business along with treating patients.
A small or individual practice doesn’t have the capital to meet requirements for a secure, interoperable EHR that meets federal review. Also, shared cost agreements force reporting of various data metrics that also takes time and money, Frenzel said.
“How does a smaller organization bear the increased cost of some of the solutions that are being put on them?” Frenzel asked.
Rep. David Schweikert, R-Arizona, was not optimistic lawmakers would be much help fixing the industry’s problems, calling Congress a “protection racket” too invested in the status quo. “The model is screwed up because we protect incumbents and we do everything we can to slow down the disruption that would make us healthier and crash the price of healthcare,” he said.

Still hope for surprise billing ban

A push to pass legislation curbing surprise billing hit a roadblock late last year, as lawmakers squabbled over jurisdiction and payers and providers offered competing policy options.
Still, Rep. Ami Bera, D-Calif., said he expects Congress will do “something on surprise billing” soon, noting the issues standing in the way are policy-related rather than partisan. “I think you’ll find something in the middle where no one got everything that they wanted but everyone got something that they wanted,” he said.
David Merritt, EVP for public affairs and strategic initiatives at America’s Health Insurance Plans, agreed that a surprise billing ban is possible this year, especially as funding for some Medicare and Medicaid programs face another extension deadline in May. The “larger political landscape” was the key problem last session. “I think we can absolutely get it over the finish line,” he said. “To me, this is one of these issues that is totally solvable if people just come together.”
But payers and providers remain far apart on the policy questions, and their respective lobbies will continue heavy spending to try to get their way.
CAHC President Joel White said he was frustrated by the failure to pass a ban last year despite public support and bipartisan proposals. “We couldn’t stop that, how are we going to take on some of these thorny issues?” he said. “I’m convinced we need to make some process changes as well as policy changes.”
Public support for change in the healthcare industry is still high. A poll presented Thursday by North Star Opinion Research showed strong voter support for a public option and weak approval of the current healthcare system. When it came to privacy issues, people weren’t particularly worried about having their personal health information stolen (financial and retail purchasing information was more of a concern) they were split over whether privacy or access was more important.
The online survey found that healthcare cost and access was voters’ top issue, beating out the economy and national security, and half believed it should be a right guaranteed by the federal government.

Transparency about more than prices

While HHS wages a public and legal battle on healthcare price transparency, efforts continue more behind the scenes to tackle transparency of quality data, Deputy Secretary Eric Hargan said Thursday at the event.
Industry players are defensive of many of the current methods for measuring and reporting quality information, despite intense pressure from the outside to reform. HHS is pushing back on providers that don’t want change with a “bottom-up scrub” of current metrics used for federal programs, but the process is a long and involved one, Hargan said.
Keeping up with tracking measures is a huge cost for practices, but “in many cases we’re finding out they’re not necessarily moving the needle in terms of providing better care to the American people,” he said.
Proposals range from having no government requirements or only the market incentive of consumer satisfaction to using numerous and strict reporting mechanisms, but there is likely a middle ground that finds the most appropriate and useful measures, he said.
“Fortunately, we have the backing of the White House and the administration broadly to undertake broad-scale reform,” he said.

App gives deaf users an on-demand ASL interpreter

For someone who is deaf, communicating with a clerk at a retail store or non-ASL-speaking friend over dinner often involves laboriously writing notes. An app called Jeenie offers an alternative: Push a button, and a live ASL interpreter appears in a video call.
“It can be challenging to communicate in everyday life with people who are not fluent in ASL,” says Laura Yellin, a woman who is deaf who tested the app’s new ASL feature, which is launching now. “For example, dealing with an issue at the dry cleaners and needing to talk to a supervisor or manager can be tricky via paper and pen or typing on the phone back and forth. It makes it a lot easier to have an interpreter available for situations like that.”
The app previously offered live interpreters for some languages—hearing customers who need a translator who speaks Mandarin or Spanish, for example, can use Jeenie to pull up a video call with that translator while traveling. The founders realized that the deaf community didn’t have a similar option for everyday life. While it’s possible to text or make a three-way call using TRS—an old-school system that lets people who are deaf or hard of hearing type messages to an operator who can read them to a hearing person, and then type back the response, or a video relay service, which allows signing—there wasn’t a simple or affordable solution for in-person conversations.
[Photo: courtesy Jeenie]
After someone using the app chooses ASL as a language and pushes a button to start a video call, an interpreter will appear within a minute, at any time of day. During the conversation, the user may use one-handed signing, a shortcut that allows them to hold the phone or tablet with the other hand. The interpreter will speak loudly so the other person in the room can clearly hear.
“As we poked around in the language service provider world, we saw very expensive fees for in-person interpreters, $90 to $125 an hour, on average,” says Kirsten Brecht Baker, the company’s CEO and cofounder. Some other companies do offer video calls with ASL interpreters, but because they target business users, have fees that are too steep for day-to-day use, she says. Jeenie charges $1 per minute and also offers packages with lower rates. The company is currently working with around 100 ASL interpreters, who are paid half of the revenue that Jeenie generates each minute.
The company is interested in potentially working with medical offices, which are required to provide ASL interpreters regardless of size, and may not currently have access to high-quality, affordable interpreters. The American Disabilities Act actually also requires that any business or organization serving the public provide accommodation to deaf customers, though some businesses may not be aware of that requirement; Jeenie is also interested in working directly with businesses and finding government funding sources to help cover the cost of the service. “We want this to be super affordable,” Baker says. The developers also hope to expand to other sign languages, such as British Sign Language or Chinese Sign Language.
On a recent day, Yellin used the app to order coffee and dessert. “It was great because I could go back and forth with the barista and ask them for their recommendations without having to write back and forth,” she says. While it’s still faster to write in some situations—if she doesn’t have questions about the menu, for example, there’s no reason to have a long conversation—she says that the app is useful in many situations, including talking with her boss. “Having face-to-face conversations is so quick and easy,” she says.

Fitbit rolls out blood oxygen tracking, eying FDA OK for sleep apnea diagnosis

Wearables giant Fitbit has rolled out a blood oxygen monitoring feature on some of its smartwatches, beating the Apple Watch on adding this functionality.
Fitbit, which Google agreed to buy in November, confirmed to FierceHealthcare that the company has activated a feature on its Charge 3, Ionic, Versa, Versa Lite and Versa 2 devices that provides users in the U.S. with blood oxygen data via the Fitbit app.
Users can see whether they are experiencing large variations in blood oxygen levels while they sleep.
The estimated oxygen variation graph provides users with an estimate of the variability of oxygen levels in their bloodstream, also referred to as SpO2. The data are derived from a combination of the red and infrared sensors on the back of the device, according to MaryEllen Green, a spokesperson for Fitbit.

The data shown in the graph are not a relative Sp02 estimate. “Being aware of variations in the oxygen levels in your bloodstream may indicate variations in your breathing during sleep. In general, variations should be low,” Green said.
Apple holds patents for blood oxygen monitoring but has yet to activate the feature in any of its devices, according to CNET. Back in 2018, Garmin introduced Pulse Ox with its Vivosmart 4 activity tracker, allowing users to gauge their blood oxygen saturation levels on the spot or periodically as they sleep, CNET reported.
Health tech company Withings recently unveiled its new ScanWatch, which also has similar monitoring capabilities. However, it is still undergoing FDA clearance, according to CNET.
Fitbit’s end goal is to secure Food and Drug Administration (FDA) clearance for a sleep apnea diagnosis feature.
“Fitbit continues to collect clinical data to test and develop FDA cleared features for sleep apnea. We expect to submit for FDA clearance soon. We continue to maintain a dialogue with FDA throughout this process,” Green said on behalf of Fitbit.

Fitbit president and co-founder James Park said during the company’s second-quarter 2019 earnings call: “In terms of the FDA, we’re continuing to work with the FDA on a variety of initiatives, including around sleep apnea.” He added during the call that he couldn’t give a time frame on FDA clearance.
The wearables giant also plans to submit atrial fibrillation detection software to the FDA for regulatory review and approval, the company said in October.
Fitbit and pharmaceutical giants Bristol-Myers Squibb and Pfizer inked a multiyear partnership to accelerate the detection and diagnosis of atrial fibrillation to reduce the risk of life-threatening events such as stroke.

Once its afib detection software receives FDA clearance, Fitbit will work with the BMS-Pfizer Alliance to provide those who are alerted by the wearable device of a potential heart rhythm irregularity with appropriate information to help encourage and inform discussions with their physicians, the companies said in October.
Fitbit is expanding its healthcare ambitions. And a new study published in the Lancet Digital Health journal found that heart rate and sleep data from wearable fitness tracker watches can predict and alert public health officials to real-time outbreaks of flu more accurately than current surveillance methods.
The study used data from more than 47,000 Fitbit users in five U.S. states. By using the data, state-wide predictions of flu outbreaks were improved and acclerated, the study said.
Industry analysts see Google’s $2.1 billion acquisition of Fitbit as a data play as Fitbit’s devices now collect data—such as the number of steps taken, sleep duration, menstrual cycles and heart rate—from 27.3 million users.
The deal, expected to close this year, faces scrutiny from the Justice Department for possible antitrust issues, according to multiple media reports.

Epic is warning customers it will stop working with Google Cloud

Account reps from Epic have told customers that the medical records giant will not be pursuing further integrations with Google Cloud, CNBC’s Chrissy Farr reported on Friday.
Epic’s representatives told customers the company would instead focus its energies on Amazon Web Services and Microsoft Azure, Farr reported, citing sources with knowledge of the matter.
The reps said the company decided to halt development with Google Cloud because it wasn’t seeing sufficient interest among its health system customers to warrant the investment.
Calls to customers have come in the past few weeks, said three people with knowledge of the matter, and were directed to Epic’s hospital customers that use Google’s cloud-based technology either for medical research, data storage or for their basic IT operations, including file-sharing, according to CNBC.
The people who spoke to CNBC declined to be named because they were not authorized to speak for their organizations on the matter.

Google also is working on a health records search tool currently in the pilot phase using synthetic patient data. Using Google technologies, the tool is designed to reduce clicks when looking at a patient’s record and enables clinicians to access a unified view of data normally spread across multiple systems, including vitals, medications, labs, and notes, Google executives said in a video.
A representative from Epic said the company declined to comment on specific vendors.
Seth Hain, Epic’s vice president of R&D, said in a statement, “We invest substantial time and engineering effort in evaluating and understanding the infrastructure Epic runs on. Scalability, reliability, and security are important factors we consider when evaluating these underlying technologies.”
“We focus our effort on the infrastructure the Epic community uses today and is likely to use in the future – including both public cloud offerings and on-premises servers and storage. No part of these efforts grant infrastructure vendors the right to use the data that may reside on their infrastructure,” Hain said.
Google Cloud lags well behind AWS and Microsoft Azure in market share for cloud computing. Gartner’s latest report on the public-cloud computing infrastructure market indicates that AWS owns nearly half of the world’s public cloud infrastructure market, leading by a wide margin Microsoft (15.5%), Alibaba (7.7%), Google (4%), and IBM (1.8%).

As it seeks to expand its customer base for its cloud products, Google has scored big-name healthcare partners such as Mayo Clinic. The hospital announced in September a 10-year strategic partnership with Google to use the tech giant’s cloud platform to accelerate innovation through digital technologies.
The new development with Epic comes as Google is facing significant criticism, including scrutiny from regulators and lawmakers, regarding its data deal with health system Ascension. News broke in November that Google was collecting personal health information on millions of Americans as part of a partnership with Ascension, sparking privacy concerns.
House Democrats are pressing Google and Alphabet executives for answers on how the companies use the health data they collect and the procedures they have in place to protect that data.

The Wall Street Journal recently reported that Epic competitor Cerner decided against pursuing a data storage deal with Google, despite the tech giant offering $250 million in discounts and incentives. Google representatives were vague in answering questions about how Cerner’s data would be used, making the health-care company’s executives wary, people familiar with the matter said, according to WSJ’s reporting.
Cerner struck a deal with Amazon instead.
The failed Cerner deal reveals an emerging challenge to Google’s move into health care: gaining the trust of health care partners and the public. So far, that has hardly slowed the search giant, the WSJ reported.

Backlash on Meat Diet Recommendations Begs Question of Scientist-Industry Ties

It’s almost unheard of for medical journals to get blowback for studies before the data are published. But that’s what happened to the Annals of Internal Medicine last fall as editors were about to post several studies showing that the evidence linking red meat consumption with cardiovascular disease and cancer is too weak to recommend that adults eat less of it.
Image description not available.
Annals Editor-in-Chief Christine Laine, MD, MPH, saw her inbox flooded with roughly 2000 emails—most bore the same message, apparently generated by a bot—in a half hour. Laine’s inbox had to be shut down, she said. Not only was the volume unprecedented in her decade at the helm of the respected journal, the tone of the emails was particularly caustic.
“We’ve published a lot on firearm injury prevention,” Laine said. “The response from the NRA (National Rifle Association) was less vitriolic than the response from the True Health Initiative.”
The True Health Initiative (THI) is a nonprofit founded and headed by David Katz, MD. The group’s website describes its work as “fighting fake facts and combating false doubts to create a world free of preventable diseases, using the time-honored, evidence-based, fundamentals of lifestyle and medicine.” Walter Willett, MD, DrPH, and Frank Hu, MD, PhD, Harvard nutrition researchers who are among the top names in their field, serve on the THI council of directors.
Katz, Willett, and Hu took the rare step of contacting Laine about retracting the studies prior to their publication, she recalled in an interview with JAMA. Perhaps that’s not surprising. “Some of the researchers have built their careers on nutrition epidemiology,” Laine said. “I can understand it’s upsetting when the limitations of your work are uncovered and discussed in the open.”
Subsequent news coverage criticized the methodology used in the meat papers and raised the specter that some of the authors had financial ties to the beef industry, representing previously undisclosed conflicts of interest.
But what has for the most part been overlooked is that Katz and THI and many of its council members have numerous industry ties themselves. The difference is that their ties are primarily with companies and organizations that stand to profit if people eat less red meat and a more plant-based diet. Unlike the beef industry, these entities are surrounded by an aura of health and wellness, although that isn’t necessarily evidence-based.
State of the Science
The Annals published 5 systematic reviews—4 that included results from randomized clinical trials (RCTs) and observational studies examining the relationship between red meat and health, and a fifth that looked at health-related values and preferences about eating meat. Based on the reviews, the authors produced a guideline that concluded adults needn’t change their meat-eating habits.
In an accompanying editorial, coauthors Aaron Carroll, MD, and Tiffany Doherty, PhD, wrote that the guideline “is sure to be controversial, but it is based on the most comprehensive review of the evidence to date.”
Carroll, a regular JAMA contributor who directs the Indiana University School of Medicine’s Center for Pediatric and Adolescent Comparative Effectiveness Research, also wrote in the New York Times about the difficulties involved in conducting high-quality nutrition research.
“Even observational trials are hard to do well,” Carroll wrote. In the short-term, it’s difficult to find big differences in death and disease rates, even in large groups of people, he noted. “But quantifying what people are eating over long periods is challenging, too, because people don’t remember.”
The guideline’s lead author, Bradley Johnston, PhD, is a cofounder and director of NutriRECS, an independent group that says it uses its members’ expertise in clinical issues, nutrition, public health, and evidence-based medicine to produce nutritional guidelines that aren’t hampered by conflicts of interest. Besides systematic reviews about the relationship between dietary patterns, food, and nutrients and health outcomes, NutriRECS said it considers patient and community values, attitudes, and preferences in its guideline recommendations.
In the Annals papers, NutriRECS members and their coauthors wrote that they sought to bring scientific rigor to current meat intake guidelines based mostly on observational studies that don’t establish cause-and-effect relationships.
Johnston, an associate professor with Texas A&M University’s nutrition and food science department, and his coauthors used the GRADE (Grading of Recommendations, Assessment, Development, and Evaluations) approach to assess the quality of evidence upon which they based their guideline. The GRADE framework considers evidence from randomized controlled trials (RCTs) to be of the highest quality and observational data to be of lower quality because of residual confounding. A panel of 14 individuals from 7 countries voted on the final guideline recommendations, and 3 dissented.
The authors, who noted that their recommendations were “weak” and based on low-certainty evidence, found no statistically significant link between meat consumption and risk of heart disease, diabetes, or cancer in a dozen RCTs that had enrolled about 54 000 participants. They did find a very small disease risk reduction among people who consumed 3 fewer servings of red meat weekly in epidemiological studies that followed millions, but the association was uncertain.
The authors acknowledged that other reasons besides health—namely concerns about the environment and animal welfare—might motivate people to reduce their meat intake, although those factors did not bear on the recommendations.
“That would require a systematic review of the relevant evidence, which was beyond the scope of our work—and indeed, of our expertise,” Johnston and his coauthors commented on the Annals website in response to criticism for not considering environmental impact.
Katz and other THI members have criticized the authors’ use of GRADE because, unlike pharmaceutical research, so much nutrition research is observational and so little involves RCTs. “We can’t randomly assign people to diets for decades,” Katz told JAMA. “Even if we could…we couldn’t blind them to what they’re eating…everything about nutritional epidemiology cries out for the use of other methods [besides GRADE].”
Katz and coauthors including Willett recently published an article about a tool they constructed that deemphasizes the importance of RCTs in evaluating evidence about what they call lifestyle medicine, including diet. “We’re not anti-meat,” said Katz, founding director of the US Centers for Disease Control and Prevention–funded Prevention Research Center at Griffin Hospital, a 160-bed acute-care community hospital in Derby, Connecticut, that’s affiliated with the Frank H. Netter MD School of Medicine at Quinnipiac University and the Yale School of Medicine. “We’re just pro-science.”
The problem, said Harvard Medical School obesity specialist David Ludwig, MD, PhD, is that the science is not that good. “The average research study in nutrition is just lower quality.”
In a recent JAMA Viewpoint, Ludwig and his coauthors wrote that compared with pharmaceutical research, dietary studies are far more challenging in terms of consistency, quality control, confounding, and interpretation, which makes translating those findings into public policy “exceedingly difficult.”
Instead of coming up with tools to give more weight to observational studies in guideline development, nutrition scientists need to rethink how they design studies, John Ioannidis, MD, DSc, of the Stanford University School of Medicine, wrote in a 2018 JAMA Viewpoint.
“The field needs radical reform,” Ioannidis noted.
Word Gets Around
Demands to retract the Annals papers before they were published suggest that the journal’s embargo policy had been violated. (Embargoes prohibit reporters and press officers at the authors’ institutions from circulating articles before they’re published. Breaking an embargo is a serious breach.)
An article on the THI website states that the organization had obtained the meat articles 5 days before they were scheduled to be published online. Laine said Katz was on the Annals’ press release list because he writes a weekly column for the New Haven Register, a Connecticut newspaper.
Katz said he circulated only the press release—“that’s in the public domain”—but not the embargoed articles, among THI colleagues, telling them that the guideline “looks like it’s going to be a serious problem for us.”
Actually, embargoes apply to press releases as well as the articles themselves, said Angela Collom, the Annals media relations manager. The Annals and many other journals post releases to a website run by the American Association for the Advancement of Science that restricts access to members of the media who agree to embargo policies.
“Those channels are not public domain,” Collom said. Because Katz shared the press release, she added, the Annals dropped him from the list of journalists eligible to receive embargoed releases or articles.
Four days before the articles were published, Katz and 11 THI members sent Laine a letter asking her to “pre-emptively retract publication of these papers pending further review by your office.” The signatories included THI council members Hu and Willett; Neil Barnard, MD, president of the Physicians Committee for Responsible Medicine (PCRM); former US Surgeon General Richard Carmona, MD, MPHDavid Jenkins, MD, PhD, a nutrition professor at the University of Toronto Faculty of Medicine; and Dariush Mozaffarian, MD, DrPH, dean of the Friedman School of Nutrition Science and Policy at Tufts University.
“It’s really frightening that this group, which includes people like Walter Willett and Frank Hu at the Harvard School of Public Health, which happens to be my alma mater, were aware of this and assisting it,” Laine said.
What’s more, THI member John Sievenpiper, MD, PhD, also signed the letter to Laine even though he coauthored the NutriRECS systematic review about the relationship between meat consumption and all-cause mortality and the risk of cardiovascular disease, heart attack, and type 2 diabetes.
Laine said she contacted Sievenpiper, a nutrition scientist at the University of Toronto, after receiving the letter and pointed out that he had signed a standard form affirming his agreement with his paper’s conclusions. That had not changed, he told her, but he did not agree with the guideline paper, of which he was not an author.
Hours before the meat articles were posted and the embargo lifted, Barnard’s PCRM went so far as to petition the Federal Trade Commission (FTC) “to correct false statements regarding consumption of red and processed meat released by the Annals of Internal Medicine.” But the FTC describes its role as protecting consumers and promoting competition in the marketplace, so it’s unclear what authority or interest it would have in this case.
Despite PCRM’s name, less than 10% of its 175 000 members are physicians, according to its website, which describes the organization’s mission as “saving and improving human and animal lives through plant-based diets and ethical and effective scientific research.”
“Information Terrorism”
The rebukes continued for weeks after publication of the meat articles, but Katz didn’t comment via the typical routes of posting comments on the journal’s website or writing a letter to the editor. He said he did neither because he’s “able to react much more immediately and generate a much wider awareness with my own blog platforms.”
In his October 6 column for the New Haven Register, Katz compared the articles, which he called “a great debacle of public health” to “information terrorism” that “can blow to smithereens…the life’s work of innumerable careful scientists.”
About 3 weeks later, PCRM asked the district attorney for the City of Philadelphia, where the Annals editorial office is located, “to investigate potential reckless endangerment” resulting from the publication of the meat papers and recommendations.
Another salvo came during a recent 1-day preventive cardiology conference, where half the presentations were on plant-based diets. During his keynote address, Willett showed a slide entitled “Disinformation” that faulted several organizations and individuals: the “sensationalist media,” specifically the Annals and longtime New York Times science reporter Gina Kolata, who wrote the newspaper’s first story about the meat papers; “Big Beef,” specifically Texas A&M and nutrition scientist Patrick Stover, PhD, vice chancellor at the school and a coauthor of the NutriRECS meat consumption guideline; and “evidence-based academics,” namely NutriRECS and Gordon Guyatt, MD, MSc, chair of the panel that wrote the meat consumption guidelines.
“It was part of my talk addressing the confusion that the public gets from the media about diet and health,” Willett said in an email to JAMA. “Some of this relates to the triangle of disinformation that is…feeding into this. The same strategy is being used to discredit science on sugar and soda consumption, climate change, air pollution, and other environmental hazards.”
Guyatt, a distinguished professor at McMaster University in Hamilton, Ontario, led the development 30 years ago of the concept of evidence-based medicine. In an interview with the Canadian Broadcasting Company a few days after the meat articles were posted, Guyatt called the response to them “completely predictable” and “hysterical.”
Tufts University professor Sheldon Krimsky, PhD, described it differently. “It sounds like a political campaign,” said Krimsky, who spoke on a panel about corporate influence on public health at the annual meeting of the American Public Health Association. “I’ve seen Monsanto do the same thing on the other side.”
Krimsky, who studies linkages between science and technology, ethics and values, and public policy, said THI is part of a plant-based diet “movement.” “If Katz wrote a paper, and it was published in one of the journals, I would assume he would have to disclose his relationship with his organization.”
Steven Novella, MD, founder and executive editor of the Science-Based Medicine website and a long-time critic of Katz, was more pointed in his assessment of the THI campaign against the meat articles. “It’s a total hit job,” Novella, a Yale neurologist, told JAMA. “They have a certain number of go-to strategies…in order to dismiss any scientific findings they don’t like.” One such strategy, he said, is to lodge accusations of “tenuous” conflicts of interest.
“Confluence” or Conflict of Interest?
The New York Times was the first organization to raise the issue of potential conflicts of interest among the meat papers’ authors. An October 4 article noted that Johnston, who reported having no conflicts of interest in the 3 years prior to publication, coauthored a December 2016 Annals study that was funded by the nonprofit International Life Sciences Institute (ILSI), which is primarily supported by the food and agriculture industry.
He and his coauthors of the 2016 article used GRADE to conduct “a separate and independent review of the methodological quality of dietary guidelines that address (added) sugar recommendations,” Johnston told JAMA. They found that the evidence to support recommendations to cut back on added sugars was low to very low, highlighting “methodological deficiencies in nutritional guidelines,” Johnston said. “This paper did not say sugar is okay to consume.”
He said he received the ILSI funding in 2015, which was before the 3-year period for which he was required to report competing interests for the meat articles. However, according to a December 31 correction in the Annals, Johnston didn’t include on his personal disclosure form a grant from Texas A&M AgriLife Research that he received within the 36-month reporting period. The grant funded investigator-driven research about saturated and polyunsatured fats, according to the correction.
Johnston isn’t the only one who’s had ILSI ties. True Health Initiative member Sievenpiper served as a scientific advisor for ILSI’s Carbohydrates Committee and as vice chair of the ILSI North America Scientific Session 2018. And in late 2015, Canada’s National Post newspaper reported that the Corn Refiners Association retained Sievenpiper as an expert witness to support its case that high-fructose corn syrup is no less healthy than sugar.
Shortly after the meat papers were published, THI Director Jennifer Lutz posted an article entitled “Steak Holder Interests: Industry Funding and Nutrition Reporting,”
The article called out Stover, who coauthored the NutriRECS meat guideline, for having an undisclosed conflict of interest because his school receives funding from the beef industry. Stover is vice chancellor and dean for the Texas A&M College of Agriculture and Life Sciences, which is part of Texas A&M AgriLife. Lutz’s article noted that 44 Farms, the largest Texas producer of Black Angus cattle, has established an endowment at Stover’s school to support the International Beef Cattle Academy.
However, the beef industry provides only about 1.5% of AgriLife’s funding, which it posts online, spokeswoman Olga Kuchment said. Federal sources, such as the US Department of Agriculture, account for about half of AgriLife’s funding, Kuchment added. Besides animal science, AgriLife research areas include nutrition and food science, horticultural science, and soil and crop sciences. Although he has received AgriLife funding, Johnston said, “I personally have never had ties with the beef industry.”
Meanwhile, industry ties and other potential conflicts of interest seem to be common among THI council members and the organization itself.
Among the not-for-profit “partners” listed on the THI website are #NoBeef, the Olive Wellness Institute, which describes itself as a “science repository on the nutrition, health, and wellness benefits of olives and olive products”; and the Plantrician Project, whose mission is “to educate, equip, and empower our physicians, healthcare practitioners and other health influencers with knowledge about the indisputable benefits of plant-based nutrition.”
Among THI’s for-profit partners are Wholesome Goodness, which sells “better-for-you foods” such as chips, breakfast cereals, and granola bars “developed with guidance from renowned nutrition expert Dr David Katz”; and Quorn, which sells meatless products made of mycoprotein, or fermented fungus made into dough.
Katz, who on his personal website describes himself as an entrepreneur, bristles at the suggestion that he, his organization, or any of his council members might have conflicts of interest.
“We weren’t telling people: Buy our kumquats,” he said.
Perhaps not kumquats, but Katz, according to his curriculum vitae (CV), and Hu have received funding from the California Walnut Commission. And the T.H. Chan School of Public Health, Hu’s and Willett’s academic home, has received hundreds of thousands of dollars from the walnut group.
“I don’t think there is any basis in the world to accuse Walter Willett of conflict of interest. He and Frank Hu have genuine interest in the health effects of nuts,” Katz said. “There’s nothing fundamentally wrong [with] industry funding.”
And, Katz told JAMA, “I think there’s a big difference between conflict of interest…vs a confluence of interest. The work you do is what you care about…No one’s ever paid me to say anything I don’t believe.”
Katz is a past president of an organization called the American College of Lifestyle Medicine (ACLM), whose website states that THI was “birthed from under ACLM’s wing” in 2015, during his 2-year term. The ACLM established the American Board of Lifestyle Medicine, which isn’t recognized by the American Board of Medical Specialties. Among ACLM’s corporate “partners” is Plant Strong by Engine 2, which holds retreats “designed to foster and celebrate your plant-based potential,” and MamaSezz, which delivers “ready-to-eat whole food plant-based meals with no BS (you know, Bad Stuff).”
Carmona, the THI council member and former surgeon general, serves on the board of Herbalife Nutrition, the dietary supplements company, and as “chief of health innovation” at Canyon Ranch, “the world’s recognized leader in…luxury spa vacations.”
In a 2018 commentary entitled “Resisting influence from agri-food industries on Canada’s new food guide,” THI council member Jenkins listed under his “competing interests” dozens of research grants from companies and industry groups, including the Pulse Research Network, the Almond Board of California, the International Nut and Dried Fruit Council; Soy Foods Association of North America; the Peanut Institute; Kellogg’s Canada; and Quaker Oats Canada.
Katz’s 66-page CV provides much food for thought about industry funding of nutrition research. He lists 2 grants from Hershey Foods totaling $731 000 to study the effects of cocoa on vascular function in people with hypertension and in those with obesity. He received 4 grants totaling $662 000 from the Egg Nutrition Center, the research and education division of the American Egg Board. One of the egg grants was awarded in August 2010, around the same time he published an article entitled “Recent anthropologic and clinical research raises questions about egg/cholesterol relationship–Eggsoneration” in the Egg Nutrition Center’s Nutrition Closeup newsletter. He also received $249 701 from ISOThrive to study the effects of its eponymous “gastroenterologist recommended microFood” in overweight adults.
Katz also is senior nutrition advisor for Kind Healthy Snacks—a THI partner—and has received $153 000 in research grants from the company. In 2015, the year Katz became an advisor to Kind, it received a warning letter from the US Food and Drug Administration (FDA) for false nutrient claims, including the use of the word “healthy,” on its labels.
Consumer Confusion
Do consumers lose when nutrition researchers can’t play nice?
Timothy Caulfield, LLM, research director of the University of Alberta’s Health Law Institute and a THI council member, gave 3 public lectures in 1 week not long after Annals published the meat articles. “This issue came up at all 3,” Caulfield said.
“I understand both the concern about conflict of interest, especially in nutrition research, and the value of advocating [for] a more plant-based approach to nutrition,” he said. “But there is so much public confusion surrounding diet. I worry about any messaging that might be interpreted as dogmatic.”
Caulfield, described in a 2018 profile in Toronto’s Globe and Mail as “one of North America’s most high-profile skeptics, taking on the rising tide of pseudoscience and misinformation,” noted that “the [THI] council has many alternative medicine practitioners and embraces ‘integrative health.’ This can be difficult to square with a science-based approach.”
When asked if he planned to step down from the THI council, Caulfield said, “I’ll need to put more thought into this. I haven’t asked them to remove my name…but I haven’t been actively involved.”
The cacophony that has erupted over the meat papers is drowning out the valid points they made, Laine said.
“The sad thing is that the important messages have been lost,” she said. “Trustworthy guidelines used to depend on who were the organizations or the people they came from.” Today, though, “the public should know we don’t have great information on diet,” Laine said. “We shouldn’t make people scared they’re going to have a heart attack or colon cancer if they eat red meat.”

How state groups are working to lower healthcare prices

A RAND report on hospital pricing last May pushed many employer purchasing groups into action.
The report infuriated self-insured employers who previously didn’t know how much they were paying, at least partly due to gag clauses in contracts between providers and insurers barring disclosure of negotiated rates even to plan sponsors, said Gloria Sachdev, CEO of the Employers’ Forum of Indiana. (A bipartisan bill in Congress would outlaw such secrecy provisions.)
The RAND Corp. researchers found that hospital systems’ average prices ranged from 150% of Medicare to more than 400%. Hospitals in Indiana, Wyoming, Maine, Wisconsin, Montana and Colorado had the highest average prices relative to Medicare, while those in Michigan, Pennsylvania, New York and Kentucky had the lowest.
“The RAND analysis showed that Colorado hospitals on average are being paid 270% of Medicare,” said Robert Smith, executive director of the Colorado Business Group on Health. “We’re paying Mercedes prices and getting a Peugeot.”
Here’s what’s happening in response to price growth in four states paying higher prices:
Connecticut and Maine
Starting next year, the state of Connecticut will offer its 210,000 employees and retirees financial incentives to get care for about 45 procedures and conditions from lower-cost, higher-quality providers in its new “network of distinction.”
In addition, plan members will receive incentives to get certain procedures like joint replacements done at selected centers of excellence across the country, said Francois de Brantes, a senior vice president at Remedy Partners, which is administering the state program.
That effort will be supercharged by the Connecticut Legislature’s decision to cut the budget for public employee health benefits by 10%.
Maine has adopted a similar but more limited centers of excellence program for its state employee plan.
Colorado
In January, the Colorado Business Group on Health launched a statewide employer purchasing cooperative, including the state employee health plan, which will encourage employees to use higher-value providers.
It will work with insurers to negotiate prices benchmarked to Medicare rates and will push insurers to make those same rates available to small businesses.
The Colorado group also will use composite patient safety and quality scores from Quantros to select network providers. Employer groups say many companies are leery about steering patients without reliable quality measures.
“We must generate price sensitivity, and the only way to do that is to match the consolidated power hospitals have with consolidated purchasing power,” said Robert Smith, executive director of the Colorado Business Group on Health.
Wisconsin
The Alliance, a purchasing cooperative, has started negotiating hospital contracts for its 250 employer members, representing 100,000 lives, based on rates of 175% to 225% of Medicare. That’s substantially less than they’re current paying. The cooperative also is negotiating bundled-payment rates for orthopedic and imaging services, encouraging employer members to offer workers incentives to use providers with lower prices and higher quality.